| 000 | 01705 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514010631.0 | ||
| 264 | 0 | _c20020211 | |
| 008 | 200202s 0 0 eng d | ||
| 022 | _a0955-8810 | ||
| 024 | 7 |
_a10.1097/00008877-200107000-00002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCollins, S L | |
| 245 | 0 | 0 |
_aKappa opioid agonists alter dopamine markers and cocaine-stimulated locomotor activity. _h[electronic resource] |
| 260 |
_bBehavioural pharmacology _cJul 2001 |
||
| 300 |
_a237-45 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAnalgesics _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBenzeneacetamides |
| 650 | 0 | 4 |
_aBenzomorphans _xpharmacology |
| 650 | 0 | 4 |
_aCaudate Nucleus _xdrug effects |
| 650 | 0 | 4 |
_aCocaine _xpharmacology |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 | _aDopamine Plasma Membrane Transport Proteins |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMembrane Glycoproteins |
| 650 | 0 | 4 |
_aMembrane Transport Proteins _xdrug effects |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 |
_aNaltrexone _xpharmacology |
| 650 | 0 | 4 |
_aNerve Net _xdrug effects |
| 650 | 0 | 4 | _aNerve Tissue Proteins |
| 650 | 0 | 4 |
_aPyrrolidines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Opioid, kappa _xagonists |
| 700 | 1 | _aGerdes, R M | |
| 700 | 1 | _aD'Addario, C | |
| 700 | 1 | _aIzenwasser, S | |
| 773 | 0 |
_tBehavioural pharmacology _gvol. 12 _gno. 4 _gp. 237-45 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00008877-200107000-00002 _zAvailable from publisher's website |
| 999 |
_c11470767 _d11470767 |
||